ESC 365 - Ticagrelor or prasugrel in patients with acute coronary syndrome and high bleeding risk

ESC Professional Premium Access

Ticagrelor or prasugrel in patients with acute coronary syndrome and high bleeding risk

Session: Antithrombotic and anticoagulant therapy

Topic: Pharmacotherapy

Speaker: Doctor S. Lahu (Munich, DE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Shqipdona Lahu

German Heart Centre Munich, Munich (Germany)

0 follower

8 more presentations in this session

Associations between DAPT score and long-term mortality post PCI

Speaker: Doctor M. Tan (Melbourne, AU)

Intracoronary thrombolysis facilitated primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients: an updated meta-analysis of randomized controlled trials

Speaker: Doctor S. Alexiou (Thessaloniki, GR)

Abbreviated dual antiplatelet therapy after PCI in patients at high bleeding risk: a collaborative meta-analysis of randomized trials

Speaker: Doctor F. Costa (Messina, IT)

Perioperative risk and benefit of antiplatelet therapy in patients undergoing non-cardiac surgery within 1 year after percutaneous coronary intervention with second-generation drug-eluting stents.

Speaker: Doctor S. Lee (Seoul, KR)

Efficacy and safety of proprotein covertase subtilisin/kexin type 9 inhibitors among patients with acute coronary syndrome: a meta-analysis of randomized controlled trials

Speaker: Doctor S. Delgado (Taguig, PH)

Access the full session

Antithrombotic and anticoagulant therapy

Speakers: Doctor S. Lahu, Doctor M. Tan, Doctor S. Alexiou, Doctor F. Costa, Doctor S. Lee...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources